dbo:abstract
|
- Bromoketoprogesterone (BKP), also known as 9α-bromo-11-oxoprogesterone (BOP), and known by the tentative brand name Braxarone (Squibb), is an orally active progestin which does not appear to have been marketed. (en)
|
dbo:alternativeName
| |
dbo:casNumber
| |
dbo:chEBI
| |
dbo:fdaUniiCode
| |
dbo:pubchem
| |
dbo:thumbnail
| |
dbo:wikiPageID
| |
dbo:wikiPageLength
|
- 10211 (xsd:nonNegativeInteger)
|
dbo:wikiPageRevisionID
| |
dbo:wikiPageWikiLink
| |
dbp:br
| |
dbp:c
| |
dbp:casNumber
| |
dbp:chebi
| |
dbp:chemspiderid
| |
dbp:h
| |
dbp:iupacName
| |
dbp:o
| |
dbp:pubchem
| |
dbp:routesOfAdministration
| |
dbp:smiles
|
- CC[C@H]1CC[C@@H]2[C@@]1C (en)
|
dbp:stdinchi
| |
dbp:stdinchikey
|
- NWFOHSCPTMLQIH-WHJJYKQUSA-N (en)
|
dbp:synonyms
|
- BKP; BOP; NSC-15990; 9α-Bromo-11-oxoprogesterone; Braxarone; Bromo-oxy-progesterone; BOP; 9α-Bromopregn-4-en-3,11,20-trione; Bromopregnenetrione (en)
|
dbp:tradename
| |
dbp:unii
| |
dbp:width
| |
dbp:wikiPageUsesTemplate
| |
dcterms:subject
| |
rdf:type
| |
rdfs:comment
|
- Bromoketoprogesterone (BKP), also known as 9α-bromo-11-oxoprogesterone (BOP), and known by the tentative brand name Braxarone (Squibb), is an orally active progestin which does not appear to have been marketed. (en)
|
rdfs:label
|
- Bromoketoprogesterone (en)
|
owl:sameAs
| |
prov:wasDerivedFrom
| |
foaf:depiction
| |
foaf:isPrimaryTopicOf
| |
is dbo:wikiPageDisambiguates
of | |
is dbo:wikiPageRedirects
of | |
is dbo:wikiPageWikiLink
of | |
is foaf:primaryTopic
of | |